DD215086A5 - Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen - Google Patents

Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen Download PDF

Info

Publication number
DD215086A5
DD215086A5 DD82257409A DD25740982A DD215086A5 DD 215086 A5 DD215086 A5 DD 215086A5 DD 82257409 A DD82257409 A DD 82257409A DD 25740982 A DD25740982 A DD 25740982A DD 215086 A5 DD215086 A5 DD 215086A5
Authority
DD
German Democratic Republic
Prior art keywords
chloroform
mixture
fluoro
bis
item
Prior art date
Application number
DD82257409A
Other languages
German (de)
English (en)
Inventor
Ravi K Varma
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of DD215086A5 publication Critical patent/DD215086A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
DD82257409A 1981-08-20 1982-08-20 Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen DD215086A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/294,680 US4361559A (en) 1981-08-20 1981-08-20 Antiinflammatory 17,17-bis (substituted thio) androstenes

Publications (1)

Publication Number Publication Date
DD215086A5 true DD215086A5 (de) 1984-10-31

Family

ID=23134474

Family Applications (3)

Application Number Title Priority Date Filing Date
DD82257409A DD215086A5 (de) 1981-08-20 1982-08-20 Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen
DD82242677A DD211567A5 (de) 1981-08-20 1982-08-20 Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen
DD82257403A DD215556A5 (de) 1981-08-20 1982-08-20 Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen

Family Applications After (2)

Application Number Title Priority Date Filing Date
DD82242677A DD211567A5 (de) 1981-08-20 1982-08-20 Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen
DD82257403A DD215556A5 (de) 1981-08-20 1982-08-20 Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen

Country Status (24)

Country Link
US (1) US4361559A (da)
EP (1) EP0073026B1 (da)
JP (1) JPS5841900A (da)
KR (1) KR890000678B1 (da)
AT (1) ATE18671T1 (da)
AU (1) AU564228B2 (da)
CA (1) CA1213270A (da)
CS (1) CS235959B2 (da)
DD (3) DD215086A5 (da)
DE (1) DE3269987D1 (da)
DK (1) DK165838C (da)
ES (3) ES8308336A1 (da)
FI (1) FI78916C (da)
GR (1) GR76251B (da)
HU (1) HU187783B (da)
IE (1) IE53732B1 (da)
IL (1) IL66564A (da)
NO (1) NO159601C (da)
NZ (1) NZ201343A (da)
PH (2) PH18594A (da)
PL (2) PL141303B1 (da)
PT (1) PT75442B (da)
SU (1) SU1189353A3 (da)
ZA (1) ZA825260B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447363A (en) * 1982-07-07 1984-05-08 E. R. Squibb & Sons, Inc. Androstene-17-dithioketals
US4435326A (en) * 1982-09-09 1984-03-06 E. R. Squibb & Sons, Inc. Intermediates useful in the preparation of 17,17-bis(substituted thio)androstenes
US4420428A (en) * 1982-12-27 1983-12-13 E. R. Squibb & Sons, Inc. 16-Ketoandrostene-17-dithioketals
US4427592A (en) * 1983-01-31 1984-01-24 E. R. Squibb & Sons, Inc. Androstene-17-dithioketals
US4481144A (en) * 1984-02-03 1984-11-06 E. R. Squibb & Sons, Inc. 17-Substituted thia-17-alkyl(or alkenyl or alkynyl)androstenes
US4499021A (en) * 1984-04-12 1985-02-12 E. R. Squibb & Sons, Inc. 17β(Substituted thio)-16-ketoandrostene-17α..-carboxylic acid derivatives
US4529548A (en) * 1984-05-07 1985-07-16 E. R. Squibb & Sons, Inc. 17β-(substituted thio)androstenes
US4528138A (en) * 1984-06-20 1985-07-09 E. R. Squibb & Sons, Inc. 16-Keto-17-substituted thia-17-alkyl(or alkenyl or alkynyl) androstenes
US4529547A (en) * 1984-06-20 1985-07-16 E.R. Squibb & Sons, Inc. 17-(substituted thio)-17-(substituted dithio)androstenes
US4891367A (en) * 1987-04-22 1990-01-02 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US4868168A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steroid ointment formulation
US4868169A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steroid cream formulation
US5016635A (en) * 1988-11-29 1991-05-21 Sigmedics, Inc. Of Delaware Control of FNS via pattern variations of response EMG
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation
GB9103824D0 (en) * 1991-02-23 1991-04-10 Fisons Ag Formulation
IE922301A1 (en) * 1991-07-25 1993-01-27 Squibb & Sons Inc Selective thioketalization process, process for preparing¹thioenol ethers from thioketals, and process for the¹preparation of thioketals
DK0675897T3 (da) * 1992-12-24 1998-01-26 Rhone Poulenc Rorer Ltd Nye steroider
US5439901A (en) * 1993-07-23 1995-08-08 The Procter & Gamble Company Cyproterone thiopivalate
US5344651A (en) * 1993-07-23 1994-09-06 The Procter & Gamble Company Cyproterone acetate thioacetate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2840577A (en) * 1956-12-21 1958-06-24 Searle & Co 17-thio derivatives of estratrien-3-ol and of estratetraen-3-ol
US2949477A (en) * 1959-03-04 1960-08-16 Searle & Co 1, 3, 17-triacetoxyestra-1, 3, 5(10), 16-tetraene and congeners
US4094840A (en) * 1977-05-12 1978-06-13 E. R. Squibb & Sons, Inc. 17-Alkylthio (and arylthio) androsteno[16α,17α-b]benzodioxin-3-ones
US4091036A (en) * 1977-05-12 1978-05-23 E. R. Squibb & Sons, Inc. 17-Alkylthio (and arylthio)-1',2',3',4'-tetrahydroandrosteno [16 α, 17 α-b]naphthalenes and derivatives
US4133811A (en) * 1978-02-17 1979-01-09 E. R. Squibb & Sons, Inc. 13-Alkylthio (and arylthio)-11,17-epoxy-17-methyl-18-norandrostenes
US4146538A (en) * 1978-02-27 1979-03-27 E. R. Squibb & Sons, Inc. 17-Alkylthio (and arylthio) androsteno[17α,16α-b]benzopyran-3-ones and [16α,17α]naphthopyran-3-ones

Also Published As

Publication number Publication date
JPH035400B2 (da) 1991-01-25
DK372982A (da) 1983-02-21
ES515110A0 (es) 1983-08-16
DD215556A5 (de) 1984-11-14
PT75442B (en) 1985-01-04
PL244113A1 (en) 1984-05-21
GR76251B (da) 1984-08-04
ES521951A0 (es) 1984-07-01
CA1213270A (en) 1986-10-28
ATE18671T1 (de) 1986-04-15
JPS5841900A (ja) 1983-03-11
SU1189353A3 (ru) 1985-10-30
HU187783B (en) 1986-02-28
IL66564A0 (en) 1982-12-31
ES8406505A1 (es) 1984-07-01
KR840001183A (ko) 1984-03-28
EP0073026A1 (en) 1983-03-02
NO159601C (no) 1989-01-18
AU564228B2 (en) 1987-08-06
IE821951L (en) 1983-02-20
ES8406506A1 (es) 1984-07-01
FI822890A0 (fi) 1982-08-19
NO822823L (no) 1983-02-21
IL66564A (en) 1986-03-31
KR890000678B1 (ko) 1989-03-24
PL237936A1 (en) 1984-02-13
DE3269987D1 (en) 1986-04-24
DD211567A5 (de) 1984-07-18
DK165838C (da) 1993-06-21
AU8631882A (en) 1983-02-24
IE53732B1 (en) 1989-02-01
PL141303B1 (en) 1987-07-31
PT75442A (en) 1982-09-01
PH19857A (en) 1986-07-22
US4361559A (en) 1982-11-30
NZ201343A (en) 1985-08-16
FI78916C (fi) 1989-10-10
PH18594A (en) 1985-08-12
ZA825260B (en) 1983-05-25
NO159601B (no) 1988-10-10
ES521952A0 (es) 1984-07-01
FI78916B (fi) 1989-06-30
EP0073026B1 (en) 1986-03-19
DK165838B (da) 1993-01-25
ES8308336A1 (es) 1983-08-16
CS235959B2 (en) 1985-05-15
FI822890L (fi) 1983-02-21

Similar Documents

Publication Publication Date Title
DD215086A5 (de) Verfahren zur herstellung von 17,17-bis-(substituierten thio)-3-ketoandrostenen
EP0004975B1 (de) Corticoid-17-Alkylcarbonate, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel gegen Dermatosen
DE2910899C2 (de) 17α-Butyryloxy-11β-hydroxy-21-propionyloxy-4-pregnen-3,20-dion und topische Arzneimittel, welche diese Verbindung enthalten
DE2906017A1 (de) 13-alkyl(oder aryl)-thio-11,17-epoxy- 17-methyl-18-norandrostene und verfahren zu ihrer herstellung
DE2907539A1 (de) 17-alkylthio-(und arylthio)-androsteno eckige klammer auf 17 alpha , 16 alpha -b eckige klammer zu benzopyran- 3-one und - eckige klammer auf 16 alpha , 17 alpha -b eckige klammer zu naphthopyran-3-one sowie deren verwendung als entzuendungshemmende wirkstoffe
DE3102397A1 (de) 17(alpha)-acyloxy-5(beta)-corticoide und 17(alpha)-acyloxy-5(alpha)-corticoide
CH537917A (de) Verfahren zur Herstellung von 20-Hydroperoxysteroiden
CH651053A5 (de) Steroid-zwischenprodukte.
DE1518994A1 (de) Verfahren zur Herstellung von neuen Beta,10Alpha-Steroiden
DE2365992C3 (de) 6α-Fluor-17,21-dihydroxy-16β-methylpregna-4,9(11)-dien-3,20-dion-17,21-diacetat und Verfahren zu dessen Herstellung
EP0003341B1 (de) 11,17-substituierte Pregnane, ihre Herstellung und Verwendung zur Herstellung von pharmazeutischen Präparaten
EP0077541B1 (de) Delta-1,3,5-3-Chlor-11-Beta,16-Alpha,17-Alpha,21-tetra-(hydroxy)-pregnan-20-on-16,17-acetonidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3324403A1 (de) Androsten-17-dithioketale und diese verbindungen enthaltende arzeimittel
DE2362280A1 (de) 21-sulfinylsteroide der delta hoch 4pregnanreihe, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2929558A1 (de) Verfahren zur herstellung von ungesaettigten steroiden
DE1493178C3 (de) 6 alpha-Fluor-16 alpha-methyl-1,4pregnadien-3,20-dion-derivate und Verfahren zu ihrer Herstellung
EP0063368B1 (de) Verfahren zur Herstellung von Pregn-4-en-3,20-dionderivaten sowie 17-alpha-Äthinyl-17-beta-trifluoracetoxygon-4-en-3-onderivate und die letzteren enthaltende Arzneimittel
AT220764B (de) Verfahren zur Herstellung von neuen 3-Oxo-Δ<1,4>-6-methyl- und 3-Oxo-Δ<1,4,6>-6-methylsteroiden
DE1643010A1 (de) Verfahren zur Herstellung von 17alpha-Alkinyl-17ss-alkanoyloxy-Steroiden der Andostran- und Oestranreihe
DE2756550C2 (de) Verfahren zur Herstellung von 3,20-Dioxo-7α-halogen-4-pregnenen und 1,4-Pregnadienen, 3,20-Dioxo-7α-chlor und Brom-1,4-pregnadiene und letztere enthaltende Arzneimittel
AT300842B (de) Verfahren zur Herstellung von Verbindungen, die zwei Carbonylgruppen oder zwei Nitrilgruppen oder eine Nitril- sowie eine Carbonylgruppe enthalten
DE1443957C (de) 9 alpha-Chlor- bzw. 9 alpha-Fluor-. 16 beta-methyl-prednisolon-17,21-diester und ein Verfahren zu deren Herstellung
EP0469275A2 (de) 3-(oxo)- oder 3-(hydroxy)-substituierte 17 Alpha, 20-(Epoxy)-pregnan-20-carbonsäure-beziehungsweise-isocyanat-Derivate, ihre Verwendung und Verfahren zur Herstellung von 3-(oxo)- oder 3-(hydroxy)-substituierten 17 Alpha-(Hydroxy)-20-(oxo)-pregnan-Derivaten und der ersteren
Scheer et al. Coprostane, Cholestane and their 16β-Hydroxy Derivatives from Steroidal Sapogenins
DE2409971B2 (de) 5-cholestenderivate und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee